Ethylpropyltryptamine

Last updated

Ethylpropyltryptamine
Ethylpropyltryptamine.svg
EPT 3D.png
Clinical data
Other namesEPT; N-Ethyl-N-propyltryptamine
Drug class Serotonergic psychedelic; Hallucinogen
ATC code
  • None
Identifiers
  • N-ethyl-N-[2-(1H-indol-3-yl)ethyl]propan-1-amine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
Formula C15H22N2
Molar mass 230.355 g·mol−1
3D model (JSmol)
  • CCCN(CC)CCC1=CNC2=CC=CC=C12
  • InChI=1S/C15H22N2/c1-3-10-17(4-2)11-9-13-12-16-15-8-6-5-7-14(13)15/h5-8,12,16H,3-4,9-11H2,1-2H3
  • Key:LCDYRMYSOIVPRS-UHFFFAOYSA-N

Ethylpropyltryptamine (EPT), also known as N-ethyl-N-propyltryptamine, is a rarely encountered psychedelic drug in the tryptamine family. It has been identified in illicit products in Japan. [1]

Contents

Use and effects

EPT was not included nor mentioned in Alexander Shulgin's book TiHKAL (Tryptamines I Have Known and Loved). [2]

Interactions

Chemistry

Analogues

Analogues of EPT include methylethyltryptamine (MET), methylpropyltryptamine (MPT), diethyltryptamine (DET), dipropyltryptamine (DPT), among others. [2]

Society and culture

United Kingdom

It is illegal to sell, distribute, supply, transport or trade the pharmaceutical drug under the Psychoactive Substances Act of 2016. [3]

United States

EPT is unscheduled but it may be considered an analogue of DMT, which is a Schedule I drug under the Controlled Substances Act. As such, the sale for human consumption could be illegal under the Federal Analogue Act.

See also

References

  1. ↑ Tanaka R, Kawamura M, Hakamatsuka T, Kikura-Hanajiri R (January 2021). "Identification of six tryptamine derivatives as designer drugs in illegal products". Forensic Toxicology. 39 (1): 248–258. doi:10.1007/s11419-020-00556-5.
  2. 1 2 Shulgin A, Shulgin A (September 1997). TiHKAL: The Continuation. Berkeley, California: Transform Press. ISBN   0-9630096-9-9. OCLC   38503252.
  3. ↑ "Misuse of Drugs Act 1971". Legislation.gov.uk.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.